Evidence map›Paper›PMID 19723781›Full record

ArticleThe Journal of physiology2009

Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans.

Colin N Young, James P Fisher, Kevin M Gallagher, Adam Whaley-Connell, Kunal Chaudhary, Ronald G Victor, Gail D Thomas, Paul J Fadel

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. High-sodium diet does not worsen endothelial function in female patients with postural tachycardia syndrome.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2021
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Cardioprotective Effect ofJournal of pharmacopuncture · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Elevated muscle sympathetic activity in former smokers with heart failure.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2022
    Article
  18. Article
  19. Direct cardiac versus systemic effects of inorganic nitrite on human left ventricular function.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  20. Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Colin N YoungDepartment of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA.
James P Fisher
Kevin M Gallagher
Adam Whaley-Connell
Kunal Chaudhary
Ronald G Victor
Gail D Thomas
Paul J Fadel
Harry S. Truman Memorial Veterans' Hospital · USThe University of Texas Southwestern Medical Center · USUniversity of Missouri · US

Funding

Sympathetic overactivity & hypertension in ERSD: A role for ADMAR21DK076636 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI FADEL, PAUL J · 2007 to 2008
$407k
NIDDK NIH HHS DK076636NIDDK NIH HHS R21 DK076636
6 · The paper itself

Abstract

Animal studies have indicated that nitric oxide is a key signalling molecule involved in the tonic restraint of central sympathetic outflow from the brainstem. Extension of these findings to humans has been difficult because systemic infusion of nitric oxide synthase (NOS) inhibitors increases blood pressure due to inhibition of endothelial NOS, resulting in activation of the arterial baroreflex and subsequent inhibition of central sympathetic outflow. To overcome this confounding inhibitory influence of the baroreflex, in the current study we directly measured skin sympathetic nerve activity (SNA), which is not under baroreceptor control. Healthy, normotensive humans were studied before, during a 60 min intravenous infusion of the NOS inhibitor N(G)-nitro-l-arginine methyl ester (l-NAME; 4 mg kg(1)), and for 120 min following the infusion (i.e. 180 min total). Skin SNA and arterial blood pressure (BP) were continuously measured. BP was increased from baseline at the end of the l-NAME infusion (14 +/- 2 mmHg; P < 0.05) and remained significantly elevated for the remainder of the experiment (18 +/- 3 mmHg; P < 0.05). Similarly, systemic NOS inhibition produced time-dependent increases in skin SNA, such that skin SNA was elevated at the end of the l-NAME infusion (total activity, 200 +/- 22% baseline; P = 0.08) and was further increased at the end of the study protocol (total activity, 350 +/- 41% baseline; P < 0.05). Importantly, skin SNA remained unchanged during time and hypertensive (phenylephrine) control experiments. These findings indicate that pharmacological inhibition of NOS causes sympathetic activation and support a role of nitric oxide in central sympathetic control in humans.

Indexed as

AdultBlood PressureCentral Nervous SystemEnzyme InhibitorsFemaleHumansHypertensionInfusions, IntravenousMaleNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide SynthaseSkinSympathetic Nervous SystemEnzyme InhibitorsNG-Nitroarginine Methyl EsterNitric OxideNitric Oxide Synthase

Identifiers

PMID19723781
PMCPMC2770160
OpenAlexW2115119379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.